Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients: a long-term follow-up study

Background: Due to graft denervation, sinus tachycardia is a common problem after heart transplantation, underlining the importance of heart rate control without peripheral effects. However, long-term data regarding the effects of ivabradine, a novel If channel antagonist, are limited in patients af...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Dösch, Andreas (VerfasserIn) , Mueller, Susanne (VerfasserIn) , Gleißner, Christian A. (VerfasserIn) , Frankenstein, Lutz (VerfasserIn) , Hardt, Stefan (VerfasserIn) , Ruhparwar, Arjang (VerfasserIn) , Ehlermann, Philipp (VerfasserIn) , Dengler, Thomas (VerfasserIn) , Katus, Hugo (VerfasserIn) , Erbel, Christian (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 4 November 2013
In: Drug design, development and therapy
Year: 2013, Jahrgang: 7, Pages: 1323-1328
ISSN:1177-8881
DOI:10.2147/DDDT.S53705
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.2147/DDDT.S53705
Verlag, lizenzpflichtig, Volltext: http://www.dovepress.com/heart-rate-reduction-for-36-months-with-ivabradine-reduces-left-ventri-peer-reviewed-article-DDDT
Volltext
Verfasserangaben:Andreas Doesch, Susanne Mueller, Christian Gleissner, Lutz Frankenstein, Stefan Hardt, Arjang Ruhparwar, Philipp Ehlermann, Thomas Dengler, Hugo A. Katus, Christian Erbel

MARC

LEADER 00000caa a2200000 c 4500
001 1743132050
003 DE-627
005 20230427215517.0
007 cr uuu---uuuuu
008 201217s2013 xx |||||o 00| ||eng c
024 7 |a 10.2147/DDDT.S53705  |2 doi 
035 |a (DE-627)1743132050 
035 |a (DE-599)KXP1743132050 
035 |a (OCoLC)1341383896 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Dösch, Andreas  |d 1976-  |e VerfasserIn  |0 (DE-588)129172758  |0 (DE-627)390355798  |0 (DE-576)297522310  |4 aut 
245 1 0 |a Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients  |b a long-term follow-up study  |c Andreas Doesch, Susanne Mueller, Christian Gleissner, Lutz Frankenstein, Stefan Hardt, Arjang Ruhparwar, Philipp Ehlermann, Thomas Dengler, Hugo A. Katus, Christian Erbel 
264 1 |c 4 November 2013 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 17.12.2020 
520 |a Background: Due to graft denervation, sinus tachycardia is a common problem after heart transplantation, underlining the importance of heart rate control without peripheral effects. However, long-term data regarding the effects of ivabradine, a novel If channel antagonist, are limited in patients after heart transplantation. - Methods: In this follow-up analysis, the resting heart rate, left ventricular mass indexed to body surface area (LVMI), tolerability, and safety of ivabradine therapy were evaluated at baseline and after 36 months in 30 heart transplant recipients with symptomatic sinus tachycardia versus a matched control group. - Results: During the study period, ivabradine medication was stopped in three patients (10% of total). Further analysis was based on 27 patients with 36 months of drug intake. The mean patient age was 53.3±11.3 years and mean time after heart transplantation was 5.0±4.8 years. After 36 months, the mean ivabradine dose was 12.0±3.4 mg/day. Resting heart rate was reduced from 91.0±10.7 beats per minute before initiation of ivabradine therapy (ie, baseline) to 81.2±9.8 beats per minute at follow-up (P=0.0006). After 36 months of ivabradine therapy, a statistically significant reduction of LVMI was observed (104.3±22.7 g at baseline versus 93.4±18.4 g at follow-up, P=0.002). Hematologic, renal, and liver function parameters remained stable during ivabradine therapy. Except for a lower mycophenolate mofetil dose at follow-up (P=0.02), no statistically significant changes in immunosuppressive drug dosage or blood levels were detected. No phosphenes were observed during 36 months of ivabradine intake despite active inquiry. - Conclusion: In line with previously published 12-month data, heart rate reduction with ivabradine remained effective and safe in chronic stable patients after heart transplantation, and also during 36-month long-term follow-up. Further, a significant reduction of LVMI was observed only during ivabradine therapy. Therefore, ivabradine may have a sustained long-term beneficial effect with regard to left ventricular remodeling in heart transplant patients. 
700 1 |a Mueller, Susanne  |e VerfasserIn  |4 aut 
700 1 |a Gleißner, Christian A.  |d 1976-  |e VerfasserIn  |0 (DE-588)124269907  |0 (DE-627)085750522  |0 (DE-576)294095578  |4 aut 
700 1 |a Frankenstein, Lutz  |d 1973-  |e VerfasserIn  |0 (DE-588)124198937  |0 (DE-627)63440766X  |0 (DE-576)328373281  |4 aut 
700 1 |a Hardt, Stefan  |e VerfasserIn  |0 (DE-588)1028380585  |0 (DE-627)730637611  |0 (DE-576)375919309  |4 aut 
700 1 |a Ruhparwar, Arjang  |e VerfasserIn  |0 (DE-588)138079021  |0 (DE-627)599042591  |0 (DE-576)306325926  |4 aut 
700 1 |a Ehlermann, Philipp  |d 1969-  |e VerfasserIn  |0 (DE-588)121563812  |0 (DE-627)705540855  |0 (DE-576)292774761  |4 aut 
700 1 |a Dengler, Thomas  |e VerfasserIn  |4 aut 
700 1 |a Katus, Hugo  |d 1951-  |e VerfasserIn  |0 (DE-588)108916618  |0 (DE-627)577155040  |0 (DE-576)289625076  |4 aut 
700 1 |a Erbel, Christian  |d 1976-  |e VerfasserIn  |0 (DE-588)132600927  |0 (DE-627)524413401  |0 (DE-576)299249603  |4 aut 
773 0 8 |i Enthalten in  |t Drug design, development and therapy  |d Albany, Auckland : Dove Medical Press, 2007  |g 7(2013), Seite 1323-1328  |h Online-Ressource  |w (DE-627)578533138  |w (DE-600)2451346-5  |w (DE-576)286025620  |x 1177-8881  |7 nnas  |a Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients a long-term follow-up study 
773 1 8 |g volume:7  |g year:2013  |g pages:1323-1328  |g extent:6  |a Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients a long-term follow-up study 
856 4 0 |u https://doi.org/10.2147/DDDT.S53705  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.dovepress.com/heart-rate-reduction-for-36-months-with-ivabradine-reduces-left-ventri-peer-reviewed-article-DDDT  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201217 
993 |a Article 
994 |a 2013 
998 |g 132600927  |a Erbel, Christian  |m 132600927:Erbel, Christian  |d 910000  |d 910100  |d 50000  |e 910000PE132600927  |e 910100PE132600927  |e 50000PE132600927  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 10  |y j 
998 |g 108916618  |a Katus, Hugo  |m 108916618:Katus, Hugo  |d 910000  |d 910100  |d 50000  |e 910000PK108916618  |e 910100PK108916618  |e 50000PK108916618  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 9 
998 |g 121563812  |a Ehlermann, Philipp  |m 121563812:Ehlermann, Philipp  |d 910000  |d 910100  |d 50000  |e 910000PE121563812  |e 910100PE121563812  |e 50000PE121563812  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 7 
998 |g 138079021  |a Ruhparwar, Arjang  |m 138079021:Ruhparwar, Arjang  |d 910000  |d 910200  |d 50000  |e 910000PR138079021  |e 910200PR138079021  |e 50000PR138079021  |k 0/910000/  |k 1/910000/910200/  |k 0/50000/  |p 6 
998 |g 1028380585  |a Hardt, Stefan  |m 1028380585:Hardt, Stefan  |d 50000  |e 50000PH1028380585  |k 0/50000/  |p 5 
998 |g 124198937  |a Frankenstein, Lutz  |m 124198937:Frankenstein, Lutz  |d 910000  |d 910100  |d 50000  |e 910000PF124198937  |e 910100PF124198937  |e 50000PF124198937  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 4 
998 |g 124269907  |a Gleißner, Christian A.  |m 124269907:Gleißner, Christian A.  |d 910000  |d 910100  |d 50000  |e 910000PG124269907  |e 910100PG124269907  |e 50000PG124269907  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 3 
998 |g 129172758  |a Dösch, Andreas  |m 129172758:Dösch, Andreas  |d 910000  |d 910100  |d 50000  |e 910000PD129172758  |e 910100PD129172758  |e 50000PD129172758  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1743132050  |e 3826595386 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1743132050"],"doi":["10.2147/DDDT.S53705"]},"physDesc":[{"extent":"6 S."}],"title":[{"title_sort":"Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients","title":"Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients","subtitle":"a long-term follow-up study"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"4 November 2013"}],"relHost":[{"recId":"578533138","origin":[{"dateIssuedDisp":"2007-","publisher":"Dove Medical Press","publisherPlace":"Albany, Auckland","dateIssuedKey":"2007"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2451346-5"],"eki":["578533138"],"issn":["1177-8881"]},"title":[{"title":"Drug design, development and therapy","title_sort":"Drug design, development and therapy"}],"pubHistory":["1.2007 -"],"note":["Gesehen am 28.05.2020"],"part":{"text":"7(2013), Seite 1323-1328","pages":"1323-1328","extent":"6","year":"2013","volume":"7"},"language":["eng"],"disp":"Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients a long-term follow-up studyDrug design, development and therapy","type":{"bibl":"periodical","media":"Online-Ressource"}}],"language":["eng"],"name":{"displayForm":["Andreas Doesch, Susanne Mueller, Christian Gleissner, Lutz Frankenstein, Stefan Hardt, Arjang Ruhparwar, Philipp Ehlermann, Thomas Dengler, Hugo A. Katus, Christian Erbel"]},"note":["Gesehen am 17.12.2020"],"person":[{"given":"Andreas","display":"Dösch, Andreas","role":"aut","family":"Dösch"},{"family":"Mueller","role":"aut","given":"Susanne","display":"Mueller, Susanne"},{"given":"Christian A.","display":"Gleißner, Christian A.","role":"aut","family":"Gleißner"},{"given":"Lutz","display":"Frankenstein, Lutz","family":"Frankenstein","role":"aut"},{"family":"Hardt","role":"aut","given":"Stefan","display":"Hardt, Stefan"},{"display":"Ruhparwar, Arjang","given":"Arjang","role":"aut","family":"Ruhparwar"},{"given":"Philipp","display":"Ehlermann, Philipp","role":"aut","family":"Ehlermann"},{"family":"Dengler","role":"aut","display":"Dengler, Thomas","given":"Thomas"},{"given":"Hugo","display":"Katus, Hugo","role":"aut","family":"Katus"},{"family":"Erbel","role":"aut","display":"Erbel, Christian","given":"Christian"}],"recId":"1743132050"} 
SRT |a DOESCHANDRHEARTRATER4201